column
Post-Marketing Surveillance Data of Adverse Events Following Immunization with Human Rabies Vaccine — China, 2021–2024
Lina Zhang, Keli Li, Yan Li, Chunxiang Fan, Yuan Li, Minrui Ren, Lei Cao, Wenzhou Yu, Zundong Yin
2026, 8(17): 495-500. DOI: 10.46234/ccdcw2026.079
Abstract FullText HTML PDF
Combination Vaccines in Routine Childhood Immunization Programs — Worldwide, 2024
Fan Zheng, Guzainuer Abudurusuli, Linlin Gong, Jiayuan Xie, Huaqing Wang
2026, 8(17): 501-506. DOI: 10.46234/ccdcw2026.080
Abstract FullText HTML PDF
The Current Status of Simultaneous Vaccination of Children Aged 0–3 Years — China, 2022–2024
Xin Liu, Yuan Liang, Zhaonan Zhang, Sha Zhang, Jiakai Ye, Ruyue Hu, Lei Cao, Huixin Peng, Li Li, Yifan Song, Wenzhou Yu
2026, 8(17): 507-512. DOI: 10.46234/ccdcw2026.081
Abstract FullText HTML PDF
A Randomized, Double-Blind, Positive-Controlled Phase III Clinical Trial of an Anti-Rabies Monoclonal Antibody for Category III Rabies Exposure in Individuals Under 18 Years — China, 2021–2023
Jingyu Li, Yu Zhao, Yan Zheng, Xuexia Zhang, Ya Jiang, Jiangshu Guo, Wenmei Bao, Yinfeng Ma, Yaoyuan Zhang, Shuyuan Yin, Yirui Ma, Lijie Wang, Xiaoqiang Liu
2026, 8(17): 513-519. DOI: 10.46234/ccdcw2026.082
Abstract FullText HTML PDF
Epidemiological Investigation of a Tuberculosis Cluster Outbreak at a University — Changsha City, Hunan Province, China, September 2023–November 2025
Cifu Xie, Pengliang Yin, Linxin Song, Zi Xiong, Liqiong Bai
2026, 8(17): 520-525. DOI: 10.46234/ccdcw2026.083
Abstract FullText HTML PDF
Vol. 7 No. 4
2026, 8(17): 526-526. DOI: 10.46234/ccdcw2026.084
Abstract FullText HTML PDF
Vol. 7 No. 43
2026, 8(17): 526-526. DOI: 10.46234/ccdcw2026.085
Abstract FullText HTML PDF